2. Academic Validation
  3. NG-497 Alleviates Microglia-Mediated Neuroinflammation in a MTNR1A-Dependent Manner

NG-497 Alleviates Microglia-Mediated Neuroinflammation in a MTNR1A-Dependent Manner

  • Inflammation. 2025 Jan 3. doi: 10.1007/s10753-024-02218-9.
Qi Li # 1 2,  Pinyi Liu # 1 2,  Xuan Zhu 1 2,  Chao Zhou 1 2,  Yujie Hu 1 2,  Shiying Cao 1 2,  Huiya Li 1 2,  Xinxin Zou 1 2,  Shenghan Gao 1 2,  Xiang Cao 1 2,  Xinyu Bao 1 2,  Yun Xu 3 4 5 6,  Jingwei Li 7 8 9 10
Affiliations

Affiliations

  • 1 Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • 2 State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China.
  • 3 Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. xuyun20042001@aliyun.com.
  • 4 State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China. xuyun20042001@aliyun.com.
  • 5 Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China. xuyun20042001@aliyun.com.
  • 6 Nanjing Neurology Clinical Medical Center, Nanjing, China. xuyun20042001@aliyun.com.
  • 7 Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. ljw323@yeah.net.
  • 8 State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China. ljw323@yeah.net.
  • 9 Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China. ljw323@yeah.net.
  • 10 Nanjing Neurology Clinical Medical Center, Nanjing, China. ljw323@yeah.net.
  • # Contributed equally.
PMID: 39751706 DOI: 10.1007/s10753-024-02218-9
Abstract

Microglia-mediated neuroinflammation plays a crucial role in multiple neurological diseases. We have previously found that Atglistatin, the mouse Adipose Triglyceride Lipase (ATGL) inhibitor, could promote lipid droplets (LDs) accumulation and suppress LPS-induced neuroinflammation in mouse microglia. However, Atglistatin was species-selective, which limited its use in clinical settings. Here, we found that NG-497, a previously identified human ATGL Inhibitor, significantly increased LDs accumulation and inhibited LPS-induced pro-inflammatory responses in human microglia. Moreover, NG-497 also protected human neurons against neurotoxic cytokines in a humanized in vitro model of neuroinflammation. However, the anti-inflammatory capacity of NG-497 was independent of its effect on ATGL. Instead, we revealed that NG-497 alleviated microglia-mediated neuroinflammation through elevating the protein level of Melatonin Receptor 1A (MTNR1A). Therefore, in this study, we uncovered a novel MTNR1A-targeting compound, which exhibited anti-inflammatory and neuroprotective effect, highlighting its potential in the treatment of neuroinflammation. Moreover, the MTNRs agonist, Ramelteon, exerts comparable anti-inflammation effects with NG-497.

Keywords

ATGL; MTNR1A; Microglia; NG-497; Neuroinflammation.

Figures
Products